The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
Live Science on MSN10h
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kindA large new study has shed light on the wider health impacts of taking Ozempic-style drugs. Weight-loss drugs like Ozempic ...
The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...
The risks of 'miracle' weight loss jabs such as Ozempic, Wegovy and Mounjaro have been laid bare by a landmark study ...
Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as ...
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback